

Fundamental dimension Equity attribute | ACMRLeader $50.55▲+2.91% Cap $3.27BP/E 22.5x QuantScore63/100 | ACLSPeer $106.58▲+1.76% Cap $3.29BP/E 35.5x QuantScore47/100 | CAMTPeer $121.16▲+1.41% Cap $5.65BP/E 151.4x QuantScore42/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
31/100 |
26/100 |
18/100 |
Valuation Multiples, PEG & DCF upside | 68/100 | 30/100 | 0/100 |
Health Piotroski, Altman Z, leverage & liquidity | 68/100 | 84/100 | 71/100 |
Growth Revenue / earnings growth & margins | 59/100 | 13/100 | 45/100 |
Sentiment Analyst ratings, targets & revisions | 92/100 | 80/100 | 76/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 22.5x | 35.5x | 151.4x |
Forward P/E (next FY) | 22.8x | 26.0x | 33.4x |
EV / EBITDA (TTM) | 9.9x | 24.9x | 199.1x |
Price / Sales | 3.1x | 3.8x | 11.1x |
Price / Free Cash Flow | -27.2x | 50.2x | — |
PEG ratio | 0.83 | -0.92 | -2.08 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 3 / 9 | 4 / 9 | 3 / 9 |
Altman Z-Score | 3.44 (Safe) | 8.25 (Safe) | 7.01 (Safe) |
Total debt / equity | 0.19 | 0.04 | 0.69 |
Quick ratio | 2.7x | 3.2x | 6.6x |
Interest coverage | 18.1x | 17.2x | — |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +15.2% | -17.6% | +15.6% |
Net income growth YoY | -9.2% | -40.2% | -57.2% |
Gross margin (TTM) | 43.8% | 43.0% | 50.1% |
Operating margin (FY) | 12.1% | 14.2% | 25.8% |
FCF margin (FY) | -7.4% | 12.8% | 25.7% |
5. Trailing price performancePrice change over period |
1M return | -33.6% | -8.2% | -16.5% |
3M return | -40.0% | -20.5% | -18.0% |
6M return | -9.9% | -25.5% | -40.3% |
Year to date | +28.1% | +32.7% | +13.9% |
1Y return | +21.2% | +27.9% | +1.7% |
3Y return | +169.6% | -28.8% | +129.2% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $0.1113 -99.8% premium | $59.18 -44.5% premium | $30.30 -75.0% premium |
Wall Street consensus target | $113.20 +123.9% · range $75.00–$136.00 | $140.00 +31.4% · range $140.00–$140.00 | $178.71 +47.5% · range $152.00–$200.00 |
Consensus stance | 80% Buy20% Hold0% Sell | 77% Buy15% Hold8% Sell | 77% Buy23% Hold-0% Sell |